The role of stem cell-derived tissues in novel treatments for cardiac ailments

Abstract

Curbs on animal testing mean human tissues derived from induced pluripotent stem cells offer a promising platform in discovering novel treatments for cardiac ailments. In the realm of research and development in novel treatments for cardiac ailments, the use of animal models, such as mice, presents inherent limitations due to physiological discrepancies between species, specifically between humans and experimental animals. For instance, the heart rate in mice can surpass 500 beats per minute, a rate considerably faster than that observed in humans.